Coral Laboratories Intrinsic Value
Coral Laboratories intrinsic value. Coral Laboratories (CORALAB) median intrinsic value is ₹795.29 from 10 valuation models (range ₹166–₹1184), vs current price ₹552.00 — +44.1% upside (Trading Below Calculated Value), margin of safety 30.6%. Read CORALAB ex-dividend dates for the complete payout history and dividend yield track record.
CORALAB Valuation Methods Summary — DCF, Graham Number & P/E
Coral Laboratories intrinsic value across 10 models vs current price ₹552.00 — upside/downside and value range per method. For current market price and key ratios, visit Coral Laboratories stock price NSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1183.60 | ₹946.88 - ₹1420.32 | +114.4% | EPS: ₹53.80, Sector P/E: 22x |
| Book Value Method | asset | ₹1045.00 | ₹940.50 - ₹1149.50 | +89.3% | Book Value/Share: ₹522.50, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹535.00 | ₹481.50 - ₹588.50 | -3.1% | Revenue/Share: ₹267.50, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹725.00 | ₹652.50 - ₹797.50 | +31.3% | EBITDA: ₹29.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹543.33 | ₹434.66 - ₹652.00 | -1.6% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹860.80 | ₹774.72 - ₹946.88 | +55.9% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹830.90 | ₹747.81 - ₹913.99 | +50.5% | Revenue Growth: 5.9%, Adj P/E: 15.4x |
| ROE Based Valuation | profitability | ₹475.00 | ₹427.50 - ₹522.50 | -13.9% | ROE: 9.1%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹795.29 | ₹715.76 - ₹874.82 | +44.1% | EPS: ₹53.80, BVPS: ₹522.50 |
| Dividend Yield Method | dividend | ₹165.60 | ₹149.04 - ₹182.16 | -70.0% | DPS: ₹2.00, Target Yield: 2.5% |
CORALAB Intrinsic Value vs Market Price — All Valuation Models
Coral Laboratories fair value range ₹166–₹1184 vs current market price ₹552.00 across 10 valuation models. Compare with CORALAB stock valuation models to assess whether the stock is under or overvalued.
CORALAB Intrinsic Value Analysis — Undervalued or Overvalued?
Coral Laboratories median intrinsic value ₹795.29, current price ₹552.00 — Trading Below Calculated Value by 44.1%, margin of safety 30.6%.
What is the intrinsic value of CORALAB?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Coral Laboratories (CORALAB) is ₹795.29 (median value). With the current market price of ₹552.00, this represents a +44.1% variance from our estimated fair value.
The valuation range spans from ₹165.60 to ₹1183.60, indicating ₹165.60 - ₹1183.60.
Is CORALAB undervalued or overvalued?
Based on our multi-method analysis, Coral Laboratories (CORALAB) appears to be trading below calculated value by approximately 44.1%.
CORALAB Financial Health — Key Ratios vs Industry Benchmarks
Coral Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 44.25 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 9.1% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 19.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.44x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
CORALAB Cash Flow Quality — Operating & Free Cash Flow
Coral Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹16 Cr | ₹7 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹13 Cr | ₹12 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹6 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |